ALTRINSIC GLOBAL ADVISORS LLC - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 89 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALTRINSIC GLOBAL ADVISORS LLC ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q2 2018$4,158,000
+9.5%
41,858
-10.7%
0.16%
+7.2%
Q1 2018$3,796,000
+2.8%
46,8580.0%0.15%
+7.7%
Q4 2017$3,691,000
-14.4%
46,858
+0.3%
0.14%
-12.9%
Q3 2017$4,310,00046,7120.16%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2018
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders